Therapeutic Solutions International, Inc. (TSOI)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 6, 2026, 4:00 PM EST
-50.00%
Market Cap 7.05K
Revenue (ttm) 85.32K
Net Income (ttm) -2.41M
Shares Out 7.05B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 262,500
Average Volume 89,890
Open 0.0001
Previous Close 0.0001
Day's Range 0.0001 - 0.0001
52-Week Range 0.0000 - 0.0003
Beta 0.50
RSI 39.37
Earnings Date Mar 27, 2026

About TSOI

Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, and traumatic brain injury, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production. The company also produces n... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 3
Stock Exchange OTCMKTS
Ticker Symbol TSOI
Full Company Profile

Financial Performance

In 2023, TSOI's revenue was $98,994, a decrease of -52.12% compared to the previous year's $206,767. Losses were -$2.17 million, -43.11% less than in 2022.

Financial Statements

News

There is no news available yet.